Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
Hung-Hsien Chiang,1 Deng-Chyang Wu,2 Pin-I Hsu,3 Chao-Hung Kuo,2 Wei-Chen Tai,1 Shih-Cheng Yang,1 Keng-Liang Wu,1 Chih-Chien Yao,1 Cheng-En Tsai,1 Chih-Ming Liang,1 Yao-Kuang Wang,2 Jiunn-Wei Wang,2 Chih-Fang Huang,4 Seng-Kee Chuah,1 on behalf of the Taiwan Acid-Related Disease St...
Saved in:
Main Authors: | Chiang HH (Author), Wu DC (Author), Hsu PI (Author), Kuo CH (Author), Tai WC (Author), Yang SC (Author), Wu KL (Author), Yao CC (Author), Tsai CE (Author), Liang CM (Author), Wang YK (Author), Wang JW (Author), Huang CF (Author), Chuah SK (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
by: Frye JW, et al.
Published: (2015) -
Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
by: Kim HC, et al.
Published: (2023) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
by: Cardile S, et al.
Published: (2012) -
Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
by: Mingxing HOU, et al.
Published: (2020) -
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: Focus on delayed-release esomeprazole
by: Elizabet V Guimarães, et al.
Published: (2010)